APA (7th ed.) Citation

Rexer, B. N., & Arteaga, C. L. (2012). Intrinsic and acquired resistance to HER2-targeted therapies in HER2 gene-amplified breast cancer: Mechanisms and clinical implications. Critical reviews in oncogenesis, 17(1), 1. https://doi.org/10.1615/critrevoncog.v17.i1.20

Chicago Style (17th ed.) Citation

Rexer, Brent N., and Carlos L. Arteaga. "Intrinsic and Acquired Resistance to HER2-targeted Therapies in HER2 Gene-amplified Breast Cancer: Mechanisms and Clinical Implications." Critical Reviews in Oncogenesis 17, no. 1 (2012): 1. https://doi.org/10.1615/critrevoncog.v17.i1.20.

MLA (9th ed.) Citation

Rexer, Brent N., and Carlos L. Arteaga. "Intrinsic and Acquired Resistance to HER2-targeted Therapies in HER2 Gene-amplified Breast Cancer: Mechanisms and Clinical Implications." Critical Reviews in Oncogenesis, vol. 17, no. 1, 2012, p. 1, https://doi.org/10.1615/critrevoncog.v17.i1.20.